Pfizer Testing Abuse-Deterrent Compound Of Oxycodone and Naltrexone (En)
New Orleans—A unique formulation of an extended-release oxycodone plus sequestered naltrexone (an opioid antagonist), ALO-02, may deliver safety and efficacy for pain control and also mitigate the drug "high" from tampering with the capsule (e.g., crushing) that often occurs with abuse of prescription opioids. The compound is currently in Phase III of testing. "We are one of the first companies to...
Διαβασε περισσότερα